Remote Interventions for Menthol Cigarette Use
Comparing Remotely-delivered Interventions to Promote Cessation Among Adults Who Smoke Menthol Cigarettes
2 other identifiers
interventional
1,200
0 countries
N/A
Brief Summary
The purpose of this study is to evaluate whether a digital, incentive-based program, used in conjunction with traditional quitline (QL) services, can be beneficial to quitline callers who smoke menthol cigarettes. The services evaluated focus on coaching, support, and/or incentives for individuals who wish to quit smoking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2026
CompletedFirst Posted
Study publicly available on registry
January 21, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2030
Study Completion
Last participant's last visit for all outcomes
April 1, 2030
May 26, 2026
January 1, 2026
3.6 years
January 12, 2026
May 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Smoking Cessation
Participants will self-report (yes/no) past 30-day combustible tobacco use.
3-, 6-, 9- and 12- months post baseline
Secondary Outcomes (1)
Smoking Cessation With Lapses
3-, 6-, 9- and 12- months post baseline
Study Arms (2)
Quitline (QL)
ACTIVE COMPARATORParticipants complete QL services
Quitline (QL) + App
ACTIVE COMPARATORParticipants complete QL services and download our incentive-based mobile app
Interventions
QL services include scheduled and on-demand phone and digital interactions with a coach, as well as optional ancillary services and nicotine replacement therapy by mail.
The app-based intervention incentivizes participants for daily check-ins, smoking cessation, and QL calls. Participants also receive encouragement to set a smoking quit date from a study interventionist and receive motivational messages in the app.
Eligibility Criteria
You may qualify if:
- adults (ages 18+) who call partnered quitlines (QL); and
- currently smoke menthol cigarettes; and
- are fluent in English; and
- plan to live in the United States for the full trial duration; and
- have daily smartphone access (including data access) or are willing to use a study-provided smartphone and data plan
- ability to provide informed consent
You may not qualify if:
- not ready to set a quit date within 30 days; or
- have not smoked in the past 7 days
- Inability to speak/understand English
- Conditions precluding informed consent or understanding of intervention or assessment content
- PI discretion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lara Coughlin, PhD
University of Michigan
- PRINCIPAL INVESTIGATOR
Erin Bonar, PhD
University of Michigan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 12, 2026
First Posted
January 21, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
April 1, 2030
Study Completion (Estimated)
April 1, 2030
Last Updated
May 26, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
Consistent with sponsor requirements, de-identified data will be shared with the Patient Centered Outcomes Research Institute (PCORI), its collaborators, and associated research partners.